There are 2867 resources available
1070P - Previous viral infections assessed by pan-virus phage immunoprecipitation sequencing (PhIP-Seq) predict response to immune checkpoint blockers (ICBs) in non-small cell lung cancer (NSCLC)
Presenter: Filippo Dall'Olio
Session: Poster session 15
1413P - Tumor transcriptomic profiling of patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) who do not achieve optimal PSA response to intensified androgen deprivation therapy (ADT-I)
Presenter: Vinay Mathew Thomas
Session: Poster session 11
800P - Number needed to treat (NNT) and number needed to harm (NNH) to estimate clinical efficacy and safety of new adjuvant (Adj) therapies for resected stage (St) II-III melanoma
Presenter: Diego Zara
Session: Poster session 03
1071P - Trustworthy artificial intelligence models using real-world and circulating genomics data for the prediction of immunotherapy efficacy in non-small cell lung cancer patients
Presenter: Arsela Prelaj
Session: Poster session 15
1414P - Treatment efficacy and safety of 177Lu-PSMA radioligand therapy in octogenarians with metastatic castration-resistant prostate cancer
Presenter: Robert Tauber
Session: Poster session 11
801P - Neoadjuvant checkpoint inhibitor immunotherapy (IMT) for resectable mucosal melanoma (MM)
Presenter: Joel Ho
Session: Poster session 03
1072P - Prognostic role of immune checkpoints mRNA expression in peripheral blood of non-small cell lung cancer patients treated with immune checkpoint inhibitors
Presenter: CHARA PAPADAKI
Session: Poster session 15
1415P - Phase II trial of a DNA vaccine with nivolumab in patients with PSA-recurrent, castration-sensitive prostate cancer (nmCSPC)
Presenter: Douglas McNeel
Session: Poster session 11
802P - Demography and clinical outcomes of adjuvant therapy in Spain: Results from GEM 1801 study
Presenter: Salvador Martin Algarra
Session: Poster session 03
1073P - Relationship between basal metabolism, nivolumab clearance and survival in metastatic non-small cell lung cancer patients of the ELY study
Presenter: Alicja Puszkiel
Session: Poster session 15